Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from wistar-kyoto rats

American Journal of Hypertension

Volumn 22, Issue 7, 2009, Pages 770-776

  Yang, Jian ^a,b   Cui, Zhigang ^b   He, Duofen ^b   Ren, Hongmei ^b   Han, Yu ^b   Yu, Changqing ^b   Fu, Chunjiang ^b   Wang, Zheng ^c   Yang, Chengming ^b   Wang, Xukai ^b   Zhou, Lin ^b   Asico, Laureano D ^c   Villar, Van Anthony M ^c   Hopfer, Ulrich ^c   Mi, Mantian ^a   Zeng, Chunyu ^b   Jose, Pedro A ^c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; FENOLDOPAM; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RECEPTOR SUBTYPE; WORTMANNIN; INSULIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL IMMORTALIZATION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT; ANIMAL; CELL CULTURE; GENE EXPRESSION; METABOLISM; PHYSIOLOGY; RAT; STIMULATION;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION; HUMANS; INSULIN; KIDNEY TUBULES, PROXIMAL; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, INSULIN; RECEPTORS, DOPAMINE D5; SODIUM-POTASSIUM-EXCHANGING ATPASE; STIMULATION, CHEMICAL;

EID: 67649366083     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.69     Document Type: Article

References (36)

1. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 2006; 103:17985-17990.
2. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19:233-246.
3. Banday AA, Fazili FR, Lokhandwala MF. Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C. Am J Physiol Renal Physiol 2007; 293:F877-F884.
4. Boden G, Homko C, Mozzoli M, Zhang M, Kresge K, Cheung P. Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention. Diabetes 2007; 56:248-255.
5. Baum M. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 1987; 79:1104-1109.
6. Tsuchida H, Imai G, Shima Y, Satoh T, Owada S. Mechanism of sodium loadinduced hypertension in non-insulin dependent diabetes mellitus model rats: defective dopaminergic system to inhibit Na-K-ATPase activity in renal epithelial cells. Hypertens Res 2001; 24:127-135.
7. Banday AA, Asghar M, Hussain T, Lokhandwala MF. Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin. Hypertension 2003; 41:1353-1358.
8. Zeng C, Yang Z, Asico LD, Jose PA. Regulation of blood pressure by D5 dopamine receptors. Cardiovasc Hematol Agents Med Chem 2007; 5:241-248.
9. Yang Z, Sibley DR, Jose PA. D5 dopamine receptor knockout mice and hypertension. J Recept Signal Transduct Res 2004; 24:149-164.
10. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS 3rd, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 2002; 22: 10801-10810.
11. Sanada H, Xu J, Watanabe H, Jose PA, Felder RA. Differential expression and regulation of dopamine-1 (D-1) and dopamine-5 (D-5) receptor function in human kidney. Am J Hypertens 2000; 13:156A.
12. Xu J, Li XX, Albrecht FE, Hopfer U, Carey RM, Jose PA. Dopamine(1) receptor, G(salpha), and Na(+)-H(+) exchanger interactions in the kidney in hypertension. Hypertension 2000; 36:395-399.
13. Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, Felder RA, Jose PA. Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003; 41:604-610.
14. Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P, Zheng S, Jones JE, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA. Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res 2006; 99:494-500.
15. Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol 2006; 70:676-685.
16. Bobalova J, Mutafova-Yambolieva VN. Activation of the adenylyl cyclase/protein kinase A pathway facilitates neural release of beta-nicotinamide adenine dinucleotide in canine mesenteric artery. Eur J Pharmacol 2006; 536:128-132.
17. Lei J, Mariash CN, Bhargava M, Wattenberg EV, Ingbar DH. T3 increases Na-KATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294:L749-L754.
18. Inui T, Mori Y, Watanabe M, Takamaki A, Yamaji J, Sohma Y, Yoshida R, Takenaka H, Kubota T. Physiological role of L-type Ca2+ channels in marginal cells in the stria vascularis of guinea pigs. J Physiol Sci 2007; 57:287-298.
19. Ren Z, Raucci FJ Jr, Browe DM, Baumgarten CM. Regulation of swelling-activated Cl(-) current by angiotensin II signalling and NADPH oxidase in rabbit ventricle. Cardiovasc Res 2008; 77:73-80.
20. Silva E, Gomes P, Soares-da-Silva P. Overexpression of Na(+)/K (+)-ATPase parallels the increase in sodium transport and potassium recycling in an in vitro model of proximal tubule cellular ageing. J Membr Biol 2006; 212:163-175.
21. Chisalita SI, Arnqvist HJ. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. Am J Physiol Endocrinol Metab 2004; 286:E896-E901.
22. Atchley DW, Loeb RF, Richards DW, Benedict EM, Driscoll ME. On diabetic acidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest 1933; 12:297-326.
23. Miller JH, Bogdonoff MD. Antidiuresis associated with administration of insulin. J Appl Physiol 1954; 6:509-512.
24. Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001; 38:773-778.
25. Cravchik A, Gejman PV. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics 1999; 9:199-206.
26. Horiuchi A, Takeyasu K, Mouradian MM, Jose PA, Felder RA. D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A. Mol Pharmacol 1993; 43:281-285.
27. Zhang MZ, Wang S, Yao B, Fan X, Xu J, Wu G, Harris RC. Inhibition of intrarenal dopamine synthesis predisposes to salt-sensitive hypertension. J Am Soc Nephrol 2007; 18:21A.
28. Zhang MZ, Yao B, McKanna JA, Harris RC. Cross talk between the intrarenal dopaminergic and cyclooxygenase-2 systems. Am J Physiol Renal Physiol 2005; 288:F840-F845.
29. Zeng C, Luo Y, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 2003; 42:787-792.
30. Hegde SS, Chen CJ, Lokhandwala MF. Involvement of endogenous dopamine and DA-1 receptors in the renal effects of atrial natriuretic factor in rats. Clin Exp Hypertens A 1991; 13:357-369.
31. Rubí B, Ljubicic S, Pournourmohammadi S, Carobbio S, Armanet M, Bartley C, Maechler P. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 2005; 280:36824-36832.
32. Kok P, Roelfsema F, Frölich M, van Pelt J, Stokkel MP, Meinders AE, Pijl H. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab 2006; 291:E1038-E1043.
33. Umrani DN, Goyal RK. Fenoldopam treatment improves peripheral insulin sensitivity and renal function in STZ-induced type 2 diabetic rats. Clin Exp Hypertens 2003; 25:221-233.
34. Banday AA, Siddiqui AH, Menezes MM, Hussain T. Insulin treatment enhances AT1 receptor function in OK cells. Am J Physiol Renal Physiol 2005; 288: F1213-F1219.
35. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soares-da-Silva P, Creswell K, Guillemette G, Sibley DR, Eisner G, Gildea JJ, Felder RA, Jose PA. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 2008; 118:2180-2189.
36. Gildea JJ, Wang X, Jose PA, Felder RA. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension 2008; 51:360-366.